When Payment Systems Collide The Effect of Hospitalization on Anemia in Renal Dialysis Patients

被引:5
|
作者
Turenne, Marc N. [1 ,2 ]
Hirth, Richard A. [2 ]
Messana, Joseph M. [3 ]
Turner, Jason S. [5 ]
Sleeman, Kathryn K. [4 ]
Wheeler, John R. C. [2 ]
机构
[1] Univ Michigan, Kidney Epidemiol & Cost Ctr, Sch Publ Hlth, Ann Arbor, MI 48103 USA
[2] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48103 USA
[3] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48103 USA
[4] Univ Michigan, Dept Biostat, Ann Arbor, MI 48103 USA
[5] St Louis Univ, Dept Hlth Management & Policy, St Louis, MO 63103 USA
关键词
payment system; financial incentives; unintended consequences; renal failure; anemia management; hospitalization; Medicare; ACUTE MYOCARDIAL-INFARCTION; QUALITY; CARE; TIME; DISPARITIES;
D O I
10.1097/MLR.0b013e3181c161ce
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Different types of providers often face differing financial incentives for providing similar types of care. This may have implications for payment systems that target improvements in care requiring multiple types of providers. Objectives: The objective of this study was to determine how hospitalization influences the anemia of Medicare patients with chronic renal failure, where anemia is treated under a prospective payment system during hospitalizations and under a fee-for-service system during outpatient renal dialysis. Methods: We examined the effects of time in hospital and reason for hospitalization on levels of anemia among 87,263 Medicare renal dialysis patients with a hospital stay of 3 days or more during 2004. Medicare claims were used to measure changes in hematocrit between the month before and the month after hospital discharge, and to classify admissions with a high risk of anemia. Multilevel models were used to study variation in outcomes across providers. Results: Longer time in the hospital was associated with worsening anemia. As expected, larger declines in hematocrit occurred following admissions for conditions or procedures with a high risk of anemia. However, we observed a similar effect of time in the hospital for admissions both with and without a high risk of anemia. There were relatively large differences in anemia outcomes across both individual hospitals and physicians. Conclusions: Hospitalization-related anemia increases the need for care by outpatient renal dialysis providers. Efforts to improve care through payment system design are more likely to be successful if financial incentives are aligned across care settings.
引用
收藏
页码:296 / 305
页数:10
相关论文
共 50 条
  • [41] The effect of renal transplantation on quality of sleep in former dialysis patients
    Brekke, Fredrik B.
    Waldum-Grevbo, Bard
    von der Lippe, Nanna
    Os, Ingrid
    TRANSPLANT INTERNATIONAL, 2017, 30 (01) : 49 - 56
  • [42] Darbepoetin alfa is safe and effective for the treatment of renal anemia in diabetic and elderly dialysis patients.
    Martinez-Castelao, A
    Bestard, O
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 603A - 603A
  • [43] Renal anemia and hyporesponsiveness to ESA for preservation of residual kidney function in patients undergoing peritoneal dialysis
    Imaizumi, Takahiro
    Hasegawa, Takeshi
    Kosugi, Takaaki
    Nishiwaki, Hiroki
    Abe, Masanori
    Hanafusa, Norio
    Honda, Hirokazu
    Tsuruya, Kazuhiko
    Ito, Yasuhiko
    Kuragano, Takahiro
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [44] Event rates of hospitalization-associated convulsions in dialysis patients in the united states renal data system
    Gastanaga, Victor
    Stryker, Scott
    Shibata, Atsuko
    McCroskery, Peter
    Mix, T. Christian
    Zhao, Sean
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S197 - S198
  • [45] Effect of Darbepoetin Alfa on Renal Anemia in Japanese Hemodialysis Patients
    Kusaba, Tetsuro
    Ishida, Ryo
    Nakayama, Mayuka
    Kato, Hisato
    Uchiyama, Hitoji
    Sato, Katsuaki
    Mori, Yasukiyo
    Matsubara, Hiroaki
    Kajita, Yoshihiro
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2009, 59 (09): : 435 - 439
  • [47] Efficacy,safety and tolerance of continuous erythropoietin receptor activator intravenous administration on anemia correction in dialysis patients with chronic renal anemia
    钱家麒
    China Medical Abstracts(Internal Medicine), 2013, 30 (01) : 51 - 51
  • [48] EFFECT OF HUMAN RECOMBINANT ERYTHROPOIETIN ON ANEMIA AND DIALYSIS EFFICIENCY IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    STEINHAUER, HB
    LUBRICHBIRKNER, I
    DREYLING, KW
    SCHOLLMEYER, P
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1991, 21 (01) : 47 - 52
  • [49] Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic pepticle and hospitalization in patients with heart failure and anemia
    Palazzuoli, Alberto
    Silverberg, Donald
    Iovine, Francesca
    Capobianco, Stefano
    Giannotti, Giovanna
    Calabro, Anna
    Campagna, Maria Stella
    Nuti, Ranuccio
    AMERICAN HEART JOURNAL, 2006, 152 (06) : 1096.e9 - 1096.e15
  • [50] Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis
    Chow, Tam-Lin
    Chan, Tony Tung-Fei
    Ho, Yiu-Wing
    Lam, Siu-Ho
    ARCHIVES OF SURGERY, 2007, 142 (07) : 644 - 648